A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T cell immunity in vivo

Protein-based vaccines offer safety and cost advantages but require adjuvants to induce immunity. Glucopyranosyl Lipid A (GLA) is a new synthetic non-toxic analogue of lipopolysaccharide. In mice, in comparison to non-formulated LPS and another analog Monophosphoryl Lipid A, formulated GLA induced h...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Pantel, Austin, Cheong, Cheolho, Dandamudi, Durga, Shrestha, Elina, Mehandru, Saurabh, Brane, Luke, Ruane, Darren, Teixeira, Angela, Bozzacco, Leonia, Steinman, Ralph M, Longhi, Paula M
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3517108/
https://ncbi.nlm.nih.gov/pubmed/22002164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201141855
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk